Curis, Inc.

516 articles about Curis, Inc.

• Skin Cancer Breakthrough? Genentech, Inc. and Curis, Inc. Experimental Drug GDC-0449 Shrinks Advanced Skin Cancer

  4/15/2008

• Curis, Inc. Announces Preclinical Efficacy Data for CUDC-101 at American Association for Cancer Research Annual Meeting 2008

  4/14/2008

• Curis, Inc. Announces GDC-0449 Phase I Clinical Data Presented at American Association for Cancer Research Annual Meeting 2008

  4/14/2008

• Curis, Inc. Announces Presentations at American Association for Cancer Research Annual Meeting 2008

  4/9/2008

• Curis, Inc. Announces Presentation at the 235th American Chemical Society National Meeting

  4/7/2008

• Curis, Inc. Announces Phase II Clinical Plan for Hedgehog Antagonist Presented by Collaborator Genentech, Inc.

  3/14/2008

• Wyeth Ends Collaboration with Curis, Inc.

  3/10/2008

• Curis, Inc. Reports Fourth Quarter and Year-End 2007 Financial Results

  2/14/2008

• Curis, Inc. to Release Second Quarter 2007 Financial Results and Hold Conference Call on February 14, 2008

  2/7/2008

• Curis, Inc. to Present at the Biotechnology Industry Organization (BIO) CEO & Investor Conference 2008

  2/6/2008

• Curis, Inc. Announces Sale of its BMP-7 Assets to Stryker Corporation

  12/28/2007

• Curis, Inc. Announces Appointment of Stephen K. Carter, M.D. to its Board of Directors

  12/19/2007

• Curis, Inc. Reports Decision to Advance a Systemically Administered Hedgehog Antagonist into Phase II Clinical Testing

  12/12/2007

• Curis, Inc. Reports Third Quarter 2007 Financial Results

  10/30/2007

• Curis, Inc. Announces Presentation at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

  10/25/2007

• Curis, Inc. to Release Third Quarter 2007 Financial Results and Hold Conference Call on October 30, 2007

  10/23/2007

• Curis, Inc. Announces Presentation at CHI's "Discovery on Target: Developing Inhibitors for Promising Drug Targets" Conference

  10/17/2007

• Curis, Inc. Announces Initiation of Expansion Cohort in Collaborator Genentech, Inc.'s Phase I Clinical Trial of a Systemically Administered Hedgehog Antagonist

  10/16/2007

• Curis, Inc. to Present at Biotechnology Industry Organization (BIO) InvestorForum 2007

  10/3/2007

• Curis, Inc. Provides Program Update on Development Candidate CUDC-101 and Its Targeted Cancer Drug Development Platform

  9/25/2007